Canine Leishmaniasis: Epidemiology, Diagnosis, Pathogenesis, Treatment and Vaccine
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Vaccines and Therapeutic Developments".
Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 6803
Special Issue Editors
Interests: visceral leishmaniasis; canine leishmaniasis; cutaneous leishmaniasis; diagnostic; immunopathology; animal leishmaniasis
Special Issues, Collections and Topics in MDPI journals
Interests: visceral leishmaniasis; canine leishmaniasis; cutaneous leishmaniasis; diagnostic; immunopathology; animal leishmaniasis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Leishmaniasis is a group of parasitic infectious diseases that are caused by protozoa of the genus Leishmania. In general, we can separate leishmaniasis into tegumentary leishmaniasis and visceral leishmaniasis. Dogs are considered as the main urban carriers of the disease in its visceral form in Central and South America, as well as in the Mediterranean basin. In addition, the disease has a high mortality rate for dogs, and we do not have efficient drugs or vaccines. Leishmaniases are considered to be neglected in terms of research and the involvement of pets in the transmission cycle increases the risk for humans. Leishmaniasis vectors are Phlebotomine insects with predominantly wild behavior, but show clear adaptations to urban environments. On the other hand, dogs are frequently infected with dermotropic species, which cause disease, but the role of the dog in this context is underexplored. In this way, no health guideline clearly indicates how to treat or take care of dogs with tegumentary leishmaniasis. It is extremely important for human and veterinary medicine to increase our knowledge of several aspects of these diseases, ranging from epidemiology and their pathogenesis mechanisms to the development of vaccines for dogs. This Special Issue aims to publish original articles, reviews, case reports and communications that are related to pathogenesis, testing new drugs, new treatment strategies, identification of target molecules with potential use in treatment/prevention and serological, molecular, and parasitological diagnoses that can be used to improve the control of canine leishmaniasis.
Dr. Fernanda Nazaré Morgado
Dr. Renato Porrozzi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- canine leishmaniasis
- serological diagnosis
- pathogenesis
- immunophatogenesis
- immunology
- molecular diagnosis
- parasitological diagnosis
- treatment
- visceral leishmaniasis
- cutaneous leishmaniasis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.